LEO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 1.557
AS - Asia 808
EU - Europa 778
SA - Sud America 208
AF - Africa 25
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.387
Nazione #
US - Stati Uniti d'America 1.469
IT - Italia 412
SG - Singapore 378
BR - Brasile 172
CN - Cina 153
IN - India 105
DE - Germania 70
CA - Canada 68
GB - Regno Unito 63
SE - Svezia 58
VN - Vietnam 54
FI - Finlandia 32
HK - Hong Kong 29
NL - Olanda 24
RU - Federazione Russa 20
FR - Francia 16
ZA - Sudafrica 14
JP - Giappone 13
MX - Messico 13
TR - Turchia 13
ID - Indonesia 12
AR - Argentina 10
PL - Polonia 10
RO - Romania 10
IL - Israele 9
UA - Ucraina 9
AU - Australia 8
ES - Italia 8
CH - Svizzera 7
CZ - Repubblica Ceca 7
EC - Ecuador 7
MT - Malta 7
CO - Colombia 6
IQ - Iraq 6
PK - Pakistan 6
AT - Austria 5
IR - Iran 5
PE - Perù 5
BD - Bangladesh 4
SA - Arabia Saudita 4
BE - Belgio 3
MA - Marocco 3
NO - Norvegia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BG - Bulgaria 2
CL - Cile 2
CY - Cipro 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
KE - Kenya 2
LT - Lituania 2
MN - Mongolia 2
NG - Nigeria 2
PH - Filippine 2
TW - Taiwan 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
IE - Irlanda 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
LK - Sri Lanka 1
OM - Oman 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
TT - Trinidad e Tobago 1
Totale 3.387
Città #
Chandler 218
Singapore 195
Dallas 184
Santa Clara 95
Milan 88
Bengaluru 85
Hefei 85
Lawrence 57
Princeton 57
Catanzaro 56
Ashburn 49
Munich 45
London 39
Wilmington 36
Chicago 35
Hong Kong 29
Boardman 24
Ottawa 22
Redwood City 22
Los Angeles 21
Ho Chi Minh City 19
Turku 19
Des Moines 18
New York 17
Montreal 15
Helsinki 13
São Paulo 13
Brooklyn 12
Hanoi 12
Palermo 12
Rome 12
Boston 11
Atlanta 10
Johannesburg 10
Tokyo 9
Messina 8
San Nicola Manfredi 8
Shanghai 8
Warsaw 8
Council Bluffs 7
San Francisco 7
The Dalles 7
Toronto 7
Amsterdam 6
Beijing 6
Cosenza 6
Olomouc 6
Stockholm 6
West Jordan 6
Bologna 5
Casalnuovo di Napoli 5
Catania 5
Curinga 5
Falls Church 5
Guangzhou 5
Istanbul 5
Mexico City 5
Montague 5
Norwalk 5
Nuremberg 5
Padova 5
Rio de Janeiro 5
Tel Aviv 5
Vancouver 5
Ankara 4
Ann Arbor 4
Assago 4
Aversa 4
Brasília 4
Charlotte 4
Lima 4
Redmond 4
Rende 4
Seattle 4
Viagrande 4
Augusta 3
Bari 3
Battipaglia 3
Brussels 3
Columbus 3
Costabissara 3
Curitiba 3
Fergus 3
Florence 3
Florianópolis 3
Hanover 3
Lamezia Terme 3
Missaglia 3
Montegiordano 3
Naples 3
Nova Iguaçu 3
Pune 3
Queens 3
Quito 3
Sant'anastasia 3
Santiago 3
Shenzhen 3
Taranto 3
Turin 3
Vallefiorita 3
Totale 1.934
Nome #
Genetics of reflex seizures and epilepsies in humans and animals 137
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 116
Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model 85
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats 71
L’ipericina modifica l’attività theta cerebrale e produce effetti antidepressivo-simili: studio mediante qEEG in un modello sperimentale di depressione 67
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability 66
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy 62
N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy 62
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: Data from an in vivo model 61
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression 60
Anthelminthic medicinal plants in veterinary ethnopharmacology: A network meta-analysis following the PRISMA-P and PROSPERO recommendations. 59
Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis 59
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 58
Huperizine A Receptors Cortico-Hippocampal Functional Connectivity after Bilateral AMPA Lesion of the Nucleus Basalis of Meinert 56
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 54
Huperizine A reduces neuronal loss and enhances brain expression of nerve growth factor and high-affinity receptor TrkA, and reverses memory and cognitive deficits, in rats with excitotoxic lesion of nucleus basalis magnocellularis 51
Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin 51
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 50
Cognitive impairment in the WAG/Rij rat absence model is secondary to absence seizures and depressive-like behavior 49
The Anticonvulsant Activity of a Flavonoid-Rich Extract from Orange Juice Involves both NMDA and GABA-Benzodiazepine Receptor Complexes 49
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects 49
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 49
Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary 48
Renal denervation for resistant hypertension 48
Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors 48
Everolimus improves memory and learning while worsening depressive- and anxiety-like behavior in an animal model of depression 48
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis 47
Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation  47
The antiepileptic drug levetiracetam suppresses non-convulsive seizure activity and reduces ischemic brain damage in rats subjected to permanent middle cerebral artery occlusion 47
Critical appraisal of cenobamate as adjunctive treatment of focal seizures in adults 47
mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis 46
HDL (High-Density Lipoprotein) and ApoA-1 Potentially Modulate Pancreatic α-Cell Glucagon Secretion 46
Nano‐hydrogel embedded with quercetin and oleic acid as a new formulation in the treatment of diabetic foot ulcer: A pilot study 45
Antiepileptogenic effects of the selective COX-2 inhibitor etoricoxib, on the development of spontaneous absence seizures in WAG/Rij rats 43
Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis 42
The potential role of cannabinoids in epilepsy treatment. 41
Colchicine in Managing Skin Conditions: A Systematic Review 41
Diagnostic Biomarkers of Epilepsy 40
Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region 38
Vasostatin-1 restores autistic disorders in an idiopathic autism model (BTBR T+ Itpr3tf/J mice) by decreasing hippocampal neuroinflammation 38
Cannabidiol and epilepsy: Rationale and therapeutic potential 38
Cenobamate enhances the anticonvulsant effect of other antiseizure medications in the DBA/2 mouse model of reflex epilepsy 37
Antidepressants drugs for seizures and epilepsy: Where do we stand? 37
Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy 37
Seizure susceptibility to various convulsant stimuli in the BTBR mouse model of autism spectrum disorders 36
Comparative Analysis of the Treatment of Chronic Antipsychotic Drugs on Epileptic Susceptibility in Genetically Epilepsy-prone Rats 36
Long-term betamethasone 21-phosphate disodium treatment has distinct effects in CD1 and DBA/2 mice on animal behavior accompanied by opposite effects on neurogenesis 36
Long-Term High-Fat Diet Aggravates Absence Seizures and Neurobehavioral Disorders Without Inducing Metabolic Disorders in WAG/Rij Rats: Involvement of Systemic and Central Inflammation 35
Are big potassium-type Ca2+-activated potassium channels a viable target for the treatment of epilepsy? 35
Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl-2'-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 35
Biofilm-dependent airway infections: A role for ambroxol? 35
Glucagon induces the hepatic expression of inflammatory markers in vitro and in vivo 34
An In Vivo Electroencephalographic Analysis of the Effect of Riluzole against Limbic and Absence Seizure and Comparison with Glutamate Antagonists 33
Liraglutide chronic treatment prevents development of tolerance to antiseizure effects of diazepam in genetically epilepsy prone rats 33
Perampanel effects in the WAG/Rij rat model of epileptogenesis, absence epilepsy, and comorbid depressive-like behavior 33
Lamotrigine positively affects the development of psychiatric comorbidity in epileptic animals, while psychiatric comorbidity aggravates seizures 33
Quercetin-3-Oleate Contributes to Skin Wound Healing Targeting FFA1/GPR40 33
Ranolazine Attenuates Brain Inflammation in a Rat Model of Type 2 Diabetes 32
Two Olea europaea L. Extracts Reduce Harmful Effects in a Model of Neurotoxicity: Involvement of the Endoplasmic Reticulum 32
The sphingosine 1-phosphate signaling pathway in epilepsy: A possible role for the immunomodulator drug fingolimod in epilepsy treatment 32
The role of AMPA receptors and their antagonists in status epilepticus 32
Audiogenic epileptic DBA/2 mice strain as a model of genetic reflex seizures and SUDEP 31
Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence 31
Modeling poststroke epilepsy and preclinical development of drugs for poststroke epilepsy 31
Prescribing Pattern and Safety Profile of Biological Agents for Psoriasis in Real-World Practice: A Four-Year Calabrian Pharmacovigilance Analysis 30
Valproic Acid Metabolism and its Consequences on Sexual Functions 30
mTOR signalling in epilepsy and epileptogenesis: preclinical and clinical studies 30
Impact of micronutrients and nutraceuticals on cognitive function and performance in Alzheimer's disease 28
Upholding WAG/Rij rats as a model of absence epileptogenesis: Hidden mechanisms and a new theory on seizure development. 28
The Effects of Andrographis paniculata (Burm.F.) Wall. Ex Nees and Andrographolide on Neuroinflammation in the Treatment of Neurodegenerative Diseases 27
Intravenous carbamazepine for the treatment of epilepsy 27
From Cannabis to Cannabidiol to Treat Epilepsy, Where Are We? 26
Epilepsy and Alzheimer's Disease: Current Concepts and Treatment Perspective on Two Closely Related Pathologies 26
Fingolimod Exerts only Temporary Antiepileptogenic Effects but Longer-Lasting Positive Effects on Behavior in the WAG/Rij Rat Absence Epilepsy Model 25
Perampanel chronic treatment does not induce tolerance and decreases tolerance to clobazam in genetically epilepsy prone rats 23
GABAA Receptors Are Involved in the Seizure Blockage Prompted by a Polyphenol-Rich Extract of White Grape Juice in Rodents 23
First-in-Class Dual Targeting Compounds for the Management of Seizures in Glucose Transporter Type 1 Deficiency Syndrome 22
Circulating miRNAs as Novel Clinical Biomarkers in Temporal Lobe Epilepsy 22
mGlu3 metabotropic glutamate receptors as a target for the treatment of absence epilepsy: preclinical and human genetics data 22
The fast‐dissociating D2 antagonist antipsychotic JNJ‐37822681 is a neuronal Kv7 channel opener: Potential repurposing for epilepsy treatment 21
Sex Differences in Hepatic Inflammation, Lipid Metabolism, and Mitochondrial Function Following Early Lipopolysaccharide Exposure in Epileptic WAG/Rij Rats 21
Histone Deacetylase Inhibitors Show Antiepileptogenic and Antidepressant Effects in the WAG/Rij Rat Model of Absence Epilepsy 20
Efficacy and Safety of Intraarticular Therapy with Cross-Linked Hyaluronic Acid in Patients with Knee Osteoarthritis 16
Perampanel chronic treatment does not induce tolerance and decreases T tolerance to clobazam in genetically epilepsy prone rats 15
Epilepsy and Related Neuropsychiatric Comorbidities: Basic and Clinical Research 14
Totale 3.534
Categoria #
all - tutte 35.194
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.194


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021188 0 0 0 12 6 69 46 8 28 10 9 0
2021/2022217 1 8 2 44 8 12 2 40 41 25 25 9
2022/2023642 119 72 30 54 63 47 10 47 89 37 50 24
2023/2024395 65 49 30 38 23 54 25 31 6 22 17 35
2024/20251.029 131 29 43 34 86 145 45 44 134 45 126 167
2025/2026910 177 235 293 205 0 0 0 0 0 0 0 0
Totale 3.534